Gennex Laboratories Limited (BOM:531739)

Gennex Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	480.24	75.89	202.31	142.13	74.91	1.95
Short-Term Investments	-	470	400	-	-	-
Cash & Short-Term Investments	480.24	545.89	602.31	142.13	74.91	1.95
Cash Growth	-8.59%	-9.37%	323.77%	89.74%	3750.73%	-28.17%
Accounts Receivable	437.56	141.61	178.11	94.17	113.13	89.46
Other Receivables	-	25.49	12.13	3.02	8.06	10.3
Receivables	1,752	225.92	224.45	122.2	121.2	129.79
Inventory	509.59	359.4	251.75	156.92	77.37	50.18
Prepaid Expenses	-	2.59	3.46	2.43	0.98	1.34
Other Current Assets	54.58	677.49	536.16	63.13	197.36	193.43
Total Current Assets	2,797	1,811	1,618	486.83	471.82	376.69
Property, Plant & Equipment	568.77	618.25	550.24	676.46	136.98	141.26
Long-Term Investments	-	0.1	0.1	0.1	68.27	68.27
Other Intangible Assets	194.57	29.41	29.41	61.08	-	-
Long-Term Deferred Tax Assets	-	1.76	2.31	1.37	-	-
Long-Term Deferred Charges	-	90.85	90.85	90.85	-	-
Other Long-Term Assets	-	8.7	8.82	6.47	3.19	2.8
Total Assets	3,570	2,560	2,300	1,323	680.27	589.02
Accounts Payable	165.37	131.59	151.8	70.78	77.41	59.45
Accrued Expenses	93.57	5.9	4.53	6.11	6.32	5.56
Short-Term Debt	-	64.01	23.73	5.29	101.24	73.62
Current Portion of Long-Term Debt	298.7	38.18	33.47	5.25	-	-
Current Income Taxes Payable	-	77.69	52.6	33.8	20.81	18.71
Other Current Liabilities	204.51	128.18	136.92	173.91	36.31	32.9
Total Current Liabilities	762.14	445.55	403.05	295.13	242.08	190.24
Long-Term Debt	585.74	168.93	132.16	162.88	-	0.15
Long-Term Deferred Tax Liabilities	-	-	-	-	0.03	1.53
Other Long-Term Liabilities	-	0	-	-	-	-
Total Liabilities	1,348	614.48	535.21	458.01	242.11	191.92
Common Stock	242.95	227.45	227.45	180.19	126.5	126.5
Additional Paid-In Capital	-	1,002	1,002	310.7	60	60
Retained Earnings	-	568.41	405.36	303.35	242.4	201.34
Comprehensive Income & Other	1,892	68.79	68.79	9.25	9.25	9.25
Total Common Equity	2,135	1,867	1,704	803.5	438.15	397.1
Minority Interest	88.07	79	60.83	61.65	-	-
Shareholders' Equity	2,223	1,946	1,765	865.15	438.15	397.1
Total Liabilities & Equity	3,570	2,560	2,300	1,323	680.27	589.02
Total Debt	884.44	271.12	189.37	173.42	101.24	73.77
Net Cash (Debt)	-404.2	274.78	412.94	-31.28	-26.33	-71.83
Net Cash Growth	-	-33.46%	-	-	-	-
Net Cash Per Share	-1.69	1.19	1.91	-0.20	-0.21	-0.57
Filing Date Shares Outstanding	243.11	227.45	227.45	176.64	126.5	126.5
Total Common Shares Outstanding	243.11	227.45	227.45	176.64	126.5	126.5
Working Capital	2,034	1,366	1,215	191.7	229.74	186.45
Book Value Per Share	8.78	8.21	7.49	4.55	3.46	3.14
Tangible Book Value	1,940	1,837	1,674	742.41	438.15	397.1
Tangible Book Value Per Share	7.98	8.08	7.36	4.20	3.46	3.14
Land	-	118.15	109.97	114.84	84.18	84.18
Buildings	-	134.63	120.28	165.4	20.26	20.26
Machinery	-	442.8	406.79	482.89	201.7	198.97
Construction In Progress	-	52.17	23.25	0.21	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.